Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bart Petrus Anna Maria Jozef Medaer"'
Autor:
Yann Abraham, Bart Petrus Anna Maria Jozef Medaer, Weimei Sun, Greet Vanhoof, Haopeng Rui, Yusri Elsayed, Sriram Balasubramanian, Ulrike Philippar, Marcello Gaudiano, Jan Willem Thuring, Jenna D. Goldberg, Tianbao Lu, Jennifer Smit, Peter J. Connolly, James P. Edwards, Max Cummings, Emanuele Trella, John Gerecitano, Nele Vloemans, Ricardo Attar, Tony Greway, Katarzyna Wnuk-Lipinska, Jan Linders, Kristof Kimpe, Amy J. Johnson, Jaqueline Bussolari, Bas-jan van der Leede, Luc Van Nuffel, Mariette Bekkers, Katie Amssoms
Publikováno v:
Blood Cancer Discovery. 1:PO-49
Introduction: Constitutive activation of the classical nuclear factor kappa-light-chain-enhancer of activated B cells (NF κB) pathway is a clear driver of B-cell lymphomas, especially the aggressive activated B-cell (ABC) subtype of diffuse large B-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e8109699ae1dad100496dfd36f4ec75
https://doi.org/10.1158/2643-3249.lymphoma20-po-49
https://doi.org/10.1158/2643-3249.lymphoma20-po-49
Autor:
Ricardo Attar, Weimei Sun, Peter J. Connolly, Yann Abraham, Joannes T. M. Linders, Bart Petrus Anna Maria Jozef Medaer, Jenna D. Goldberg, L. van Nuffel, Kristof Kimpe, Marcello Gaudiano, Greet Vanhoof, Johannes Wilhelmus John F. Thuring, James P. Edwards, Nele Vloemans, Mariette Bekkers, Yusri Elsayed, John Gerecitano, Katie Amssoms, B.M. van der Leede, Tony Greway, E. Trella, Ulrike Philippar, K. Wnuk-Lipinska, Jennifer Smit, Maxwell D. Cummings, Tianbao Lu, Jacqueline Bussolari
Publikováno v:
Hematological Oncology. 37:128-128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6c0cefd5ac788558266b0caa15d9c6
https://doi.org/10.1002/hon.88_2629
https://doi.org/10.1002/hon.88_2629
Autor:
Fred De Clerck, Bart Petrus Anna Maria Jozef Medaer, Paul A. J. Janssen, Marie-Pierre de Béthune, A.D. Clark Jr, Frits Daeyaert, Kalyan Das, Rudi Pauwels, Stephen H. Hughes, Eddy Arnold, Ann Lampo, Maarten Vinkers, Don Ludovici, Peter D. Williams, Yulia Volovik Frenkel, Fons De Knaep, Paul Stoffels, Koen Andries, Elisabeth Thérèse Jeanne Pasquier, Jerome Guillemont, Luc Koymans, Jan Heeres, Mike Kukla, Paul J. Lewi, Marc René De Jonge, Hilde Bohets
Publikováno v:
Journal of medicinal chemistry
Ideally, an anti-HIV drug should (1) be highly active against wild-type and mutant HIV without allowing breakthrough; (2) have high oral bioavailability and long elimination half-life, allowing once-daily oral treatment at low doses; (3) have minimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccbd853f7dad053ab48f18f36bb6d01
https://hdl.handle.net/10067/623370151162165141
https://hdl.handle.net/10067/623370151162165141